Top Glove Corporation Bhd. (TGLVY)
USD 1.06
(0.0%)
USD 1.06
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 581.84 Million MYR | 39.51% |
| 2022 | 417.06 Million MYR | -13.54% |
| 2021 | 482.37 Million MYR | -12.56% |
| 2020 | 551.65 Million MYR | -77.21% |
| 2019 | 2.42 Billion MYR | 9.39% |
| 2018 | 2.21 Billion MYR | 487.93% |
| 2017 | 376.39 Million MYR | -5.77% |
| 2016 | 399.43 Million MYR | -37.2% |
| 2015 | 636.02 Million MYR | 251.94% |
| 2014 | 180.71 Million MYR | 209.5% |
| 2013 | 58.39 Million MYR | 1862.03% |
| 2012 | 2.97 Million MYR | -1.06% |
| 2011 | 3 Million MYR | -15.65% |
| 2010 | 3.56 Million MYR | -82.63% |
| 2009 | 20.53 Million MYR | -89.02% |
| 2008 | 186.98 Million MYR | -2.71% |
| 2007 | 192.19 Million MYR | -29.51% |
| 2006 | 272.66 Million MYR | 76.84% |
| 2005 | 154.19 Million MYR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 1.64 Billion MYR | -15.86% |
| 2024 Q1 | 578.78 Million MYR | -0.53% |
| 2024 Q2 | 1.73 Billion MYR | -3.61% |
| 2023 Q2 | 448.96 Million MYR | 12.22% |
| 2023 Q1 | 400.09 Million MYR | -4.07% |
| 2023 Q3 | 654.11 Million MYR | 45.69% |
| 2023 FY | 581.84 Million MYR | 39.51% |
| 2023 Q4 | 581.84 Million MYR | -11.05% |
| 2022 Q3 | 459.86 Million MYR | 2.44% |
| 2022 FY | 417.06 Million MYR | -13.54% |
| 2022 Q1 | 460.96 Million MYR | -4.44% |
| 2022 Q4 | 417.06 Million MYR | -9.31% |
| 2022 Q2 | 448.91 Million MYR | -2.61% |
| 2021 Q2 | 491.44 Million MYR | 10.51% |
| 2021 Q4 | 482.37 Million MYR | -3.49% |
| 2021 FY | 482.37 Million MYR | -12.56% |
| 2021 Q3 | 499.8 Million MYR | 1.7% |
| 2021 Q1 | 444.71 Million MYR | -19.38% |
| 2020 FY | 551.65 Million MYR | -77.21% |
| 2020 Q1 | 2.5 Billion MYR | 3.4% |
| 2020 Q3 | 1.52 Billion MYR | -35.19% |
| 2020 Q4 | 551.65 Million MYR | -63.72% |
| 2020 Q2 | 2.34 Billion MYR | -6.27% |
| 2019 Q4 | 2.42 Billion MYR | 4.96% |
| 2019 FY | 2.42 Billion MYR | 9.39% |
| 2019 Q1 | 2.25 Billion MYR | 2.08% |
| 2019 Q3 | 2.3 Billion MYR | 6.06% |
| 2019 Q2 | 2.17 Billion MYR | -3.74% |
| 2018 Q1 | 324.4 Million MYR | -13.81% |
| 2018 Q4 | 2.21 Billion MYR | 6.96% |
| 2018 Q3 | 2.06 Billion MYR | 253.49% |
| 2018 FY | 2.21 Billion MYR | 487.93% |
| 2018 Q2 | 585.25 Million MYR | 80.41% |
| 2017 Q2 | 418.47 Million MYR | 2.39% |
| 2017 Q1 | 408.69 Million MYR | 2.32% |
| 2017 Q3 | 344.64 Million MYR | -17.64% |
| 2017 FY | 376.39 Million MYR | -5.77% |
| 2017 Q4 | 376.39 Million MYR | 9.21% |
| 2016 FY | 399.43 Million MYR | -37.2% |
| 2016 Q4 | 399.43 Million MYR | -2.79% |
| 2016 Q3 | 410.88 Million MYR | -12.99% |
| 2016 Q2 | 472.21 Million MYR | -5.39% |
| 2016 Q1 | 499.12 Million MYR | -21.53% |
| 2015 Q3 | 494.65 Million MYR | 12.27% |
| 2015 FY | 636.02 Million MYR | 251.94% |
| 2015 Q1 | 381.68 Million MYR | 111.2% |
| 2015 Q2 | 440.57 Million MYR | 15.43% |
| 2015 Q4 | 636.02 Million MYR | 28.58% |
| 2014 Q1 | 49.86 Million MYR | -14.59% |
| 2014 Q3 | 190.17 Million MYR | -1.95% |
| 2014 Q2 | 193.95 Million MYR | 288.93% |
| 2014 FY | 180.71 Million MYR | 209.5% |
| 2014 Q4 | 180.71 Million MYR | -4.97% |
| 2013 Q4 | 58.39 Million MYR | 135.71% |
| 2013 Q2 | 12.01 Million MYR | 174.69% |
| 2013 Q1 | 4.37 Million MYR | 46.94% |
| 2013 FY | 58.39 Million MYR | 1862.03% |
| 2013 Q3 | 24.77 Million MYR | 106.23% |
| 2012 FY | 2.97 Million MYR | -1.06% |
| 2012 Q3 | 3.06 Million MYR | 5.08% |
| 2012 Q2 | 2.91 Million MYR | 0.0% |
| 2012 Q4 | 2.97 Million MYR | -2.87% |
| 2011 Q4 | 3 Million MYR | 0.0% |
| 2011 FY | 3 Million MYR | -15.65% |
| 2010 FY | 3.56 Million MYR | -82.63% |
| 2009 FY | 20.53 Million MYR | -89.02% |
| 2008 FY | 186.98 Million MYR | -2.71% |
| 2007 FY | 192.19 Million MYR | -29.51% |
| 2006 FY | 272.66 Million MYR | 76.84% |
| 2005 FY | 154.19 Million MYR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | -116269.0% |
| Ansell Limited | 855.59 Million USD | 31.995% |
| Ansell Limited | 857.2 Million USD | 32.123% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -2496.182% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -2779193.05% |
| Psykey, Inc. | 1.01 Million USD | -57474.213% |
| ConvaTec Group Plc | 1.31 Billion USD | 55.603% |
| ConvaTec Group Plc | 1.31 Billion USD | 55.666% |
| Encision Inc. | 1.33 Million USD | -43542.674% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -25102.093% |
| Innovative MedTech Inc. | 1.87 Million USD | -30878.45% |
| LifePoint, Inc. | 446.74 Thousand USD | -130142.423% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | -10686.529% |
| Paradigm Medical Industries, Inc. | 2.18 Million USD | -26480.402% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -239693.69% |
| SmileDirectClub, Inc. | 871.79 Million USD | 33.259% |
| Sector 10, Inc. | 164 Thousand USD | -354683.537% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 13.674% |
| SheerVision, Inc. | 75 Thousand USD | -775693.333% |
| United Health Products, Inc. | 755.98 Thousand USD | -76864.744% |
| Vasamed, Inc. | 23.45 Thousand USD | -2481115.352% |
| Wearable Health Solutions, Inc. | 2.76 Million USD | -20925.197% |
| Yubo International Biotech Limited | 790.49 Thousand USD | -73504.774% |